Controlled-release Drug Delivery Technology Market Size [2031]

Report Description

Controlled-release Drug Delivery Technology Market Outlook 2031

The global controlled-release drug delivery technology market size was valued at USD 46.3 billion in 2023 and is likely to reach USD 136.08 billion by 2031, expanding at a CAGR of 10.9% during 2023 – 2031. The growth of the market is attributed to the rising demand to tailor drug delivery systems to meet the specific needs of patients.

Growing prevalence of infectious diseases is resulting in increasing demand for drug delivery solutions, which further boosts the controlled-release drug delivery technology market. Controlled-release drug delivery technology helps to maintain steady antibiotic levels in the blood stream, which is important for treating infections effectively. Furthermore, this technology is specifically designed to release drugs at the infection area, which minimizes damage to healthy tissues.This, in turn, boosts their demand.

• CWllion individuals in the US with infectious and parasitic diseases visited the emergency department for the primary diagnosis.

Get Free Sample Report

Controlled-release drug delivery technology is a specialized method for providing medications precisely and gradually. This system allows for a regulated release of active pharmaceutical ingredients over an extended period. The system improves the therapeutic effectiveness of drugs, minimizes side effects, and enhances patient compliance. Additionally, this technology is commonly used in chronic conditions, such as hypertension, diabetes, and pain management.

The report finds that the COVID-19 pandemic boosted the market. The pandemic increased the demand for effective vaccine and drug delivery systems. Controlled-release technologies are majorly utilized in the development and distribution of COVID-19 vaccines to ensure that patients receive precise and consistent vaccine doses over time.

Impact of Artificial Intelligence (AI) on Controlled-release Drug Delivery Technology Market

The emergence of artificial intelligence is expected to propel the market. AI-powered technologies are enhancing the precision and efficiency of drug delivery systems. They are enabling the customization of drug release patterns to meet individual patient needs. Additionally, AI assists in monitoring patient responses and adapting drug delivery in real-time, which ensures the right dosage at the right time.

Controlled-release Drug Delivery Technology Market Dynamics

Get Free Sample Report

Major Drivers

Rising geriatric populations are expected to drive the market. Older adults commonly have multiple health issues that require continuous medication. Controlled-release drug delivery systems are particularly beneficial for ensuring a steady and predictable release of medication. Additionally, this system reduces the risk of adverse events and simplifies complex medication regimens, thereby boosting the market.

• As per the report published by the World Health Organization (WHO) on October 1, 2022, approximately one in six people across the globe is expected to be aged 60 years or older by 2030. Additionally, the number of individuals aged over 60 years is expected to rise from 1 billion in 2020 to 1.4 billion by 2050.

Existing Restraints

Complex manufacturing of controlled-release drug delivery systems is expected to hinder the market. The research and development of these drug delivery systems involve intricate engineering, scientific research, and clinical trials. These complexities lead to manufacturing challenges, quality control issues, and increased production costs. These factors significantly contribute to the decline in the adoption and the demand for controlled-release drug delivery systems.

Emerging Opportunities

Increasing investment in research and development (R&D) by pharmaceutical companies is expected to create immense opportunities in the market. The high R & D spending allows pharmaceutical firms to explore novel drug delivery technologies, including controlled-release drug delivery systems. Moreover, the integration of the Internet of Things (IoT) and wearable devices in drug delivery solutions allows for real-time monitoring of patients,which further propels the market.

Scope of the Controlled-release Drug Delivery Technology Market Report

The report on the market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.

Controlled-release Drug Delivery Technology Market Segment Insights

Technology Segment Analysis

Based on technology, the controlled-release drug delivery technology market is divided into targeted delivery, coacervation, wurster technique, micro encapsulation, transdermal, implants, and others. The targeted delivery segment is expected to hold a major market share during the forecast period, due to their minimum side effects.

Traditional drug delivery methods affect healthy tissues. However, targeted delivery of drugs ensures that the medication primarily reaches the affected areas. This precision is important in reducing the risk of damage to the vital organs of the patient. Moreover, targeted delivery systems are customizable to match individual patient profiles for specific health conditions, which further boosts their demand.

Get Free Sample Report

The micro encapsulation segment is expected to expand at a significant CAGR in the coming years, owing to the increasing demand for improved and accurately controlled drug release systems for unstable and complex molecules. Micro encapsulation allows for meticulous control over how and when the drug is released into the body.

The design and composition of the micro capsules are tailored to create specific release profiles. Moreover, ongoing development in micro encapsulation is expanding their potential healthcare applications and further propelling the market.

Release Mechanism Analysis

On the basis of release mechanism, the market is classified as chemically activated, feedback regulated drug delivery systems, polymer-based system, activation-modulated drug delivery system, micro reservoir partition controlled drug delivery systems, and others. The feedback regulated drug delivery systems segment is anticipated to register robust growth during the forecast period, owing to their high efficiency in treating chronic disorders.

Medical conditions, such as diabetes, hypertension, or chronic pain, require continuous medication. However, feedback-regulated systems are well-suited for such chronic conditions, asthey provide a streamlined solution, reducing the need for frequent manual dosing adjustments and self-monitoring. Furthermore, the growing number of deaths from chronic disorders is fueling the demand for feedback-regulated drug delivery systems.

• According to the report published by the World Health Organization (WHO) on September 16, 2023, approximately 41 million people die every year, due to non-communicable diseases (NCDs),which is equivalent to 74% of all global deaths.

Application Analysis

In terms of application, the controlled-release drug delivery technology market is fragmented into drug eluting stents, metered dose inhalers, oral controlled-drug delivery systems, injectable, infusion pumps, transdermal and ocular patches, and others. The oral controlled drug delivery systems segment is expected to hold a key share of the market during the projected period, due to their easy availability and wide applications.

Oral drug delivery is suitable for a wide range of medications, from pain management to chronic disease treatment. The versatility of this route makes it an ideal choice among pharmaceutical companies to cater to diverse patient populations. Moreover, the high acceptance of oral controlled drug delivery systems among patients further boosts the segment.

Get Free Sample Report

The injectable segment is projected to register a considerable CAGR during the forecast period, as these controlled-release systems are versatile and easy to apply to a wide range of therapeutic areas. They are highly used in hormonal therapies, long-acting antipsychotics, and vaccines. This versatility expands the scope of injectable drug delivery device applications and further contributes to the growth of the market.

Regional Outlook

In terms of region, the global controlled-release drug delivery technology market is segmented into Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. North America is expected to dominate the market in the coming years, due to the presence of major pharmaceutical companies in the region. Pharmaceutical companies in the region highly investing in research and development, including drug delivery technologies. Moreover, the growing burden of chronic diseases boosts the demand for controlled-release drug delivery systems.

• As per the report published by the Centers for Disease Control and Prevention on July 29, 2022, over 53.8 % of the adult population in the US diagnosed with at least one chronic condition in 2019. These chronic conditions include cancer, coronary heart disease, diabetes, hypertension, arthritis, and stroke. Additionally, around 22.3 % of the US adults had multiple chronic conditions.

The market in Asia Pacific is anticipated to expand at a rapid pace during the projection period, due to the rapid expansion of the pharmaceutical industry. These companies are focusing on providing affordable controlled drug delivery technology to emerging economies, such as India and China. Additionally, the increasing geriatric population in Asia Pacific is further propelling the market.

Get Free Sample Report